Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T CellsMatthew B. Dong, Sidi Chen, J. Zhou et al.|Cell|2019Cited by 326
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastomaRyan D. Chow, Sidi Chen, Christopher D. Guzman et al.|Nature Neuroscience|2017Cited by 247
In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastomaLupeng Ye, Sidi Chen, Jonathan J. Park et al.|Nature Biotechnology|2019Cited by 205
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapyLupeng Ye, Sidi Chen, Jonathan J. Park et al.|Cell Metabolism|2022Cited by 190
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint BlockadeGuangchuan Wang, Sidi Chen, Ryan D. Chow et al.|Cancer Discovery|2020Cited by 143